OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India
Bhagwat Gunale, Dhananjay Kapse, Sonali Kar, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 9, pp. 911-911
Closed Access | Times Cited: 7
Bhagwat Gunale, Dhananjay Kapse, Sonali Kar, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 9, pp. 911-911
Closed Access | Times Cited: 7
Showing 7 citing articles:
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice
Jianping Li, Kevin Hsu, Savannah E. Howe, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Jianping Li, Kevin Hsu, Savannah E. Howe, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Effect of Platform Type on Clinical Efficacy of SARS-CoV-2 Vaccines in Prime Vaccination Settings: A Systematic Review and Meta-Regression of Randomized Controlled Trials
Sergey V. Goryaynov, Olesya Y. Gurova
Vaccines (2024) Vol. 12, Iss. 2, pp. 130-130
Open Access
Sergey V. Goryaynov, Olesya Y. Gurova
Vaccines (2024) Vol. 12, Iss. 2, pp. 130-130
Open Access
Efficacy, immunogenicity and safety of CoronaVac® in children and adolescents aged 6 months to 17 years: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial
Qianqian Xin, Kaiqin Wang, Teck‐Hock Toh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Qianqian Xin, Kaiqin Wang, Teck‐Hock Toh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys
Christopher L. Coe, Francesca A. Nimityongskul, Gabriele R. Lubach, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 929-929
Open Access
Christopher L. Coe, Francesca A. Nimityongskul, Gabriele R. Lubach, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 929-929
Open Access
Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac®) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents
Eddy Fadlyana, Kusnandi Rusmil, Muhammad Gilang Dwi Putra, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 938-938
Open Access
Eddy Fadlyana, Kusnandi Rusmil, Muhammad Gilang Dwi Putra, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 938-938
Open Access
Assessment of Efficacy and Safety Associated with COVID-19 Vaccines: A Questionnaire Based Cross-Sectional Study
S. Adusumilli, Hari Sai Gnana Lakshmi Gadu, Devi Priyanka Marni, et al.
Indian Journal of Pharmacy Practice (2023) Vol. 16, Iss. 4, pp. 353-359
Open Access
S. Adusumilli, Hari Sai Gnana Lakshmi Gadu, Devi Priyanka Marni, et al.
Indian Journal of Pharmacy Practice (2023) Vol. 16, Iss. 4, pp. 353-359
Open Access
